PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-04

Date Title Company
04-Oct-2023  Bolt Threads to Become a Public Company, Growing its Pioneering Biomaterials Platform Through Business Combination With Golden Arrow Merger Corp. Businesswire
04-Oct-2023 AI Proteins Announces the Appointment of Dr. Robert Stein to its Scientific Advisory Board Businesswire
04-Oct-2023 Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer Businesswire
04-Oct-2023 Autobahn Therapeutics to Present at Upcoming Investor Conferences Businesswire
04-Oct-2023 Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma Businesswire
04-Oct-2023 Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19 Businesswire
04-Oct-2023 DocGo Partners with Main Line Health in Philadelphia to Provide Medical Transportation, and Agrees to Collaborate on Remote Patient Monitoring Initiatives Businesswire
04-Oct-2023 MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 Businesswire
04-Oct-2023 Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair Businesswire
04-Oct-2023 Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar
04-Oct-2023 Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio Businesswire
04-Oct-2023 ROME Expands Leadership Team with the Appointment of Industry Veteran Kyle Kuvalanka as Chief Financial Officer and Chief Business Officer Businesswire
04-Oct-2023 Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting Businesswire
04-Oct-2023 Trinity Life Sciences Introduces Launch Accelerator 2.0, the First and Only Benchmark-Based Launch Tool for Pharma Trinity Life Sciences
04-Oct-2023 Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference Foghorn Therapeutics
04-Oct-2023 Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins Businesswire
04-Oct-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
04-Oct-2023 Atriva Therapeutics Announces Publication of Proof of Concept (POC) / Phase 2a RESPIRE Study Data with Zapnometinib in Patients Hospitalized with COVID-19 B3C newswire
04-Oct-2023 XiltriX North America Announces SOC 2 Type 1 Certification for Enhanced Security and Compliance of Its Monitoring-as-a-Service Solution Newswire
04-Oct-2023 Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania Mainz BioMed N.V.